Extended Data Fig. 3
From: Regorafenib plus nivolumab in unresectable hepatocellular carcinoma: the phase 2 RENOBATE trial
Heatmap showing the Pearson correlation coefficient of each cell type upon regorafenib-nivolumab treatment.
Extended Data Fig. 3 | Nature Medicine
